- Home
- BLUE vs CALC Comparison
BLUE vs CALC Comparison
Compare BLUE & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLUE
- CALC
- Stock Information
- Founded
- BLUE 1992
- CALC 2011
- Country
- BLUE United States
- CALC United States
- Employees
- BLUE N/A
- CALC N/A
- Industry
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- BLUE Health Care
- CALC Health Care
- Exchange
- BLUE Nasdaq
- CALC Nasdaq
- Market Cap
- BLUE 36.9M
- CALC 36.0M
- IPO Year
- BLUE 2013
- CALC N/A
- Fundamental
- Price
- BLUE $5.25
- CALC $1.84
- Analyst Decision
- BLUE Hold
- CALC Strong Buy
- Analyst Count
- BLUE 7
- CALC 3
- Target Price
- BLUE $44.60
- CALC $16.33
- AVG Volume (30 Days)
- BLUE 512.7K
- CALC 75.0K
- Earning Date
- BLUE 03-27-2025
- CALC 05-12-2025
- Dividend Yield
- BLUE N/A
- CALC N/A
- EPS Growth
- BLUE N/A
- CALC N/A
- EPS
- BLUE N/A
- CALC N/A
- Revenue
- BLUE $83,807,000.00
- CALC N/A
- Revenue This Year
- BLUE $218.58
- CALC N/A
- Revenue Next Year
- BLUE N/A
- CALC N/A
- P/E Ratio
- BLUE N/A
- CALC N/A
- Revenue Growth
- BLUE 184.12
- CALC N/A
- 52 Week Low
- BLUE $3.56
- CALC $1.81
- 52 Week High
- BLUE $28.60
- CALC $6.27
- Technical
- Relative Strength Index (RSI)
- BLUE 63.49
- CALC 42.94
- Support Level
- BLUE $3.65
- CALC $1.81
- Resistance Level
- BLUE $5.42
- CALC $2.21
- Average True Range (ATR)
- BLUE 0.31
- CALC 0.15
- MACD
- BLUE 0.25
- CALC 0.01
- Stochastic Oscillator
- BLUE 90.40
- CALC 47.10
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.